首页 > 最新文献

Transfusion Clinique et Biologique最新文献

英文 中文
Manual red cell exchange (RBCXm) in acute sickle cell crisis: A feasible modality in resource limited settings 急性镰状细胞危象中的人工红细胞交换(RBCXm):在资源有限的情况下一种经济有效的方法
IF 1.7 4区 医学 Q4 HEMATOLOGY Pub Date : 2024-01-18 DOI: 10.1016/j.tracli.2024.01.006
Yashaswi Dhiman , Basanta Khatiwada , Kunal Das , Manish Raturi , Dushyant Singh Gaur
{"title":"Manual red cell exchange (RBCXm) in acute sickle cell crisis: A feasible modality in resource limited settings","authors":"Yashaswi Dhiman , Basanta Khatiwada , Kunal Das , Manish Raturi , Dushyant Singh Gaur","doi":"10.1016/j.tracli.2024.01.006","DOIUrl":"10.1016/j.tracli.2024.01.006","url":null,"abstract":"","PeriodicalId":23262,"journal":{"name":"Transfusion Clinique et Biologique","volume":"31 2","pages":"Pages 119-122"},"PeriodicalIF":1.7,"publicationDate":"2024-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139498760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of the hematopoietic rare genetic diseases in Türkiye: A retrospective study 土耳其罕见造血遗传病的患病率:回顾性研究
IF 1.7 4区 医学 Q4 HEMATOLOGY Pub Date : 2024-01-11 DOI: 10.1016/j.tracli.2024.01.005
Mahir Ülgü , Serkan Yilmaz , Duygu Öztaş , Bayram Göktaş , Abdullah Akünal

Background

Rare genetic diseases are an important global public health problem. At present there are defined approximately 8120 genetic diseases in 15,465 epidemiological datasets and 70% of them start in childhood. Hematopoiesis is the production of all cellular components of blood and continues throughout life.

Objective

This study aims to present prevalence of hematopoietic rare genetic diseases recorden in Turkey.

Methods

The population of study consist of 84.680.273 people who received healthcare from the Turkish National Health Service (49.9% female, 50.1% male). TNHS collects and records electronic data which relates with illness or health information of Turkish population since 2018. All healthcare facilities utilize the Personal Electronic Health Record System (PHR), aligning with standards outlined in the Turkish National Health Data Dictionary and the Health Coding Reference Server (HCRS) established by the Ministry of Health in 2007. The data dictionary comprises essential packages such as patient application and examination records.

Results

Diagnosed female population (53.04%) were higher than male (46.96%). Data shows that most of the people with rare genetic diseases were diagnosed in Marmara Region. The overall prevalence of Hematopoietic Rare Genetic Diseases higher in the years of 2021 and 2022.

Conclusion

The prevalence increased gradually from 2018 to 2022. The consanguinity marriage seems to be the main problem which resulted higher rate of rare genetic diseases in Türkiye.

背景罕见遗传病是一个重要的全球公共卫生问题。目前,15465 个流行病学数据集中定义了约 8120 种遗传病,其中 70% 的遗传病始于儿童时期。造血是血液中所有细胞成分的生成过程,贯穿人的一生。本研究旨在介绍土耳其罕见造血遗传病的流行情况。方法研究对象包括接受土耳其国家卫生服务机构医疗服务的 84 680 273 人(49.9% 为女性,50.1% 为男性)。自 2018 年起,土耳其国家卫生服务局收集并记录与土耳其人口的疾病或健康信息相关的电子数据。所有医疗机构都使用个人电子健康记录系统(PHR),与卫生部于2007年建立的土耳其国家健康数据字典和健康编码参考服务器(HCRS)中列出的标准保持一致。数据字典包括病人申请和检查记录等基本数据包。数据显示,大多数罕见遗传病患者都是在马尔马拉地区确诊的。2021年和2022年,造血罕见遗传病的总体患病率较高。结论从2018年到2022年,患病率逐渐上升。近亲结婚似乎是土耳其罕见遗传病发病率较高的主要问题。
{"title":"Prevalence of the hematopoietic rare genetic diseases in Türkiye: A retrospective study","authors":"Mahir Ülgü ,&nbsp;Serkan Yilmaz ,&nbsp;Duygu Öztaş ,&nbsp;Bayram Göktaş ,&nbsp;Abdullah Akünal","doi":"10.1016/j.tracli.2024.01.005","DOIUrl":"10.1016/j.tracli.2024.01.005","url":null,"abstract":"<div><h3>Background</h3><p>Rare genetic diseases are an important global public health problem. At present there are defined approximately 8120 genetic diseases in 15,465 epidemiological datasets and 70% of them start in childhood. Hematopoiesis is the production of all cellular components of blood and continues throughout life.</p></div><div><h3>Objective</h3><p>This study aims to present prevalence of hematopoietic rare genetic diseases recorden in Turkey.</p></div><div><h3>Methods</h3><p>The population of study consist of 84.680.273 people who received healthcare from the Turkish National Health Service (49.9% female, 50.1% male). TNHS collects and records electronic data which relates with illness or health information of Turkish population since 2018. All healthcare facilities utilize the Personal Electronic Health Record System (PHR), aligning with standards outlined in the Turkish National Health Data Dictionary and the Health Coding Reference Server (HCRS) established by the Ministry of Health in 2007. The data dictionary comprises essential packages such as patient application and examination records.</p></div><div><h3>Results</h3><p>Diagnosed female population (53.04%) were higher than male (46.96%). Data shows that most of the people with rare genetic diseases were diagnosed in Marmara Region. The overall prevalence of Hematopoietic Rare Genetic Diseases higher in the years of 2021 and 2022.</p></div><div><h3>Conclusion</h3><p>The prevalence increased gradually from 2018 to 2022. The consanguinity marriage seems to be the main problem which resulted higher rate of rare genetic diseases in Türkiye.</p></div>","PeriodicalId":23262,"journal":{"name":"Transfusion Clinique et Biologique","volume":"31 2","pages":"Pages 81-86"},"PeriodicalIF":1.7,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139463121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role and importance of epidemiology in transfusion medicine 流行病学在输血医学中的作用和重要性
IF 1.7 4区 医学 Q4 HEMATOLOGY Pub Date : 2024-01-11 DOI: 10.1016/j.tracli.2024.01.004
Constantina Politis , Tomislav Vuk , Clive Richardson , Lida Politi , Olivier Garraud

Transfusion therapy is an indispensable form of treatment, and an important element of the public health system. Due to its origin, blood’s clinical use is associated with various risks that may cause adverse reactions and events. Progress in quality and safety of blood components has eliminated numerous risks, especially those of infectious origin. However, some risks cannot be predicted, while others cannot always be prevented.

Globalisation and climate change constantly favour the spread of infectious agents. Against this, epidemiology plays a central role in ensuring the safety of transfusion treatment, by continuous surveillance and timely identification of risks, and in the development of routine and additional tests as measures for risk mitigation. As a quantitative discipline based on research methods, epidemiology is a method of reasoning; it relies on the generation and testing of hypotheses; it utilises other scientific resources, particularly in the field of blood donation and blood transfusion, thus having many applications. The main focus falls on transfusion-transmissible infections, and on environmental or occupational diseases, injuries, disabilities and death causes at large.

The practice of epidemiology relies on a systematic approach and measurement of disease frequencies. Surveillance is a key element, involving continuously gathering, analysing, and evaluating data regarding diseases, morbidity and mortality, and disseminating the conclusions of the analyses to relevant competent authorities; in this way, action is taken for disease prevention and control. Surveillance systems also provide an important tool for risk assessment, a method to assess and characterise the critical parameters in the functionality of equipment, systems or processes of using scientific data in order to estimate the magnitude of any health effect that derives from decisions of policy makers.

Epidemiological surveillance, particularly for the incidence of adverse reactions and adverse events associated with blood transfusion at the national and international levels, has demonstrated the importance of multidisciplinary cooperation between blood and public health services.

输血治疗是一种不可或缺的治疗方式,也是公共卫生系统的重要组成部分。由于血液的来源,血液的临床使用与可能引起不良反应和事件的各种风险有关。血液成分质量和安全方面的进步已经消除了许多风险,尤其是感染性风险。然而,有些风险是无法预测的,有些风险则是无法预防的。在这种情况下,流行病学在确保输血治疗安全方面发挥着核心作用,它通过持续监测和及时发现风险,并开发常规检测和附加检测作为降低风险的措施。作为一门以研究方法为基础的定量学科,流行病学是一种推理方法;它依赖于假设的产生和检验;它利用其他科学资源,尤其是献血和输血领域的科学资源,因此应用广泛。流行病学的实践依赖于系统的方法和对疾病频率的测量。监测是一个关键因素,包括不断收集、分析和评估有关疾病、发病率和死亡率的数据,并将分析结论通报给相关主管当局;通过这种方式,采取预防和控制疾病的行动。监测系统还为风险评估提供了重要工具,是一种利用科学数据对设备、系统或流程功能的关键参数进行评估和定性的方法,以估计决策者的决策对健康造成的影响程度。流行病学监测,特别是在国家和国际层面对输血相关不良反应和不良事件的发生率进行监测,表明了血液和公共卫生服务部门之间多学科合作的重要性。
{"title":"The role and importance of epidemiology in transfusion medicine","authors":"Constantina Politis ,&nbsp;Tomislav Vuk ,&nbsp;Clive Richardson ,&nbsp;Lida Politi ,&nbsp;Olivier Garraud","doi":"10.1016/j.tracli.2024.01.004","DOIUrl":"10.1016/j.tracli.2024.01.004","url":null,"abstract":"<div><p>Transfusion therapy is an indispensable form of treatment, and an important element of the public health system. Due to its origin, blood’s clinical use is associated with various risks that may cause adverse reactions and events. Progress in quality and safety of blood components has eliminated numerous risks, especially those of infectious origin. However, some risks cannot be predicted, while others cannot always be prevented.</p><p>Globalisation and climate change constantly favour the spread of infectious agents. Against this, epidemiology plays a central role in ensuring the safety of transfusion treatment, by continuous surveillance and timely identification of risks, and in the development of routine and additional tests as measures for risk mitigation. As a quantitative discipline based on research methods, epidemiology is a method of reasoning; it relies on the generation and testing of hypotheses; it utilises other scientific resources, particularly in the field of blood donation and blood transfusion, thus having many applications. The main focus falls on transfusion-transmissible infections, and on environmental or occupational diseases, injuries, disabilities and death causes at large.</p><p>The practice of epidemiology relies on a systematic approach and measurement of disease frequencies. Surveillance is a key element, involving continuously gathering, analysing, and evaluating data regarding diseases, morbidity and mortality, and disseminating the conclusions of the analyses to relevant competent authorities; in this way, action is taken for disease prevention and control. Surveillance systems also provide an important tool for risk assessment, a method to assess and characterise the critical parameters in the functionality of equipment, systems or processes of using scientific data in order to estimate the magnitude of any health effect that derives from decisions of policy makers.</p><p>Epidemiological surveillance, particularly for the incidence of adverse reactions and adverse events associated with blood transfusion at the national and international levels, has demonstrated the importance of multidisciplinary cooperation between blood and public health services.</p></div>","PeriodicalId":23262,"journal":{"name":"Transfusion Clinique et Biologique","volume":"31 2","pages":"Pages 108-113"},"PeriodicalIF":1.7,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139463219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
S.O.S. – Save our supplies: Understanding reasons to tackle the challenge of wasted returned blood products S.O.S. - 拯救我们的供应品:了解解决退回血液制品浪费难题的原因
IF 1.7 4区 医学 Q4 HEMATOLOGY Pub Date : 2024-01-10 DOI: 10.1016/j.tracli.2024.01.003
Deep Madkaiker, Kartik Iyer, Jagriti, Deepika Chenna, Ganesh Mohan, Shamee Shastry

Objectives

To evaluate the return of blood components across different hospital areas, reasons for the same and suggest preventive strategies which might reduce out of controlled temperature storage (CTS) blood logistics and wastage.

Material and methods

A retrospective audit was carried out in the department of Transfusion Medicine from January 2019 to December 2022. Data related to returned blood components was compiled using departmental records and blood centre software entries.

Results

A total of 218 instances of returned components were noted and the total number of components returned were 442 (0.4% of all issued components) (38.4% (170) packed red blood cells, 16.2% (72) single donor cryoprecipitate concentrate, 19.6% (87) platelet concentrate and 25.5% (113) fresh frozen plasma). Components were returned back within 30 mins in only 27% (59/218) of all instances . Wards followed by high dependency units/intensive care units were noted to have the highest number of instances (86 (39.4%) and 69 (31.6%) respectively) with emergency department having the least,comprising 19 instances (8.7%). 77.9% (170/218) instances were observed for routine transfusion requests and 44.5% (97/218) of all instances could have been prevented by an appropriate clinical status assessment of the patient.

Conclusion

Stakeholders such as clinicians, transfusion laboratory professional and nursing staff must take consolidated efforts to eliminate wastage of blood components. Instances of returned blood components can be targeted by the hospital quality team as a quality improvement project.

目的评估不同医院区域血液成分的退回情况、退回原因,并提出预防策略,以减少受控温度储存(CTS)外的血液物流和浪费。结果共发现 218 例退回成分,退回成分总数为 442 个(占所有发放成分的 0.4%)(38.4%(170 个)包装红细胞、16.2%(72 个)单供体低温沉淀浓缩物、19.6%(87 个)血小板浓缩物和 25.5%(113 个)新鲜冷冻血浆)。只有 59 例(27%)在 30 分钟内送回成分。病房和高危病房/重症监护病房的返还次数最多(分别为 86 次(39.4%)和 69 次(31.6%)),急诊科最少,只有 19 次(8.7%)。77.9%(170/218)的案例发生在常规输血申请中,97/218(44.5%)的案例本可以通过对患者进行适当的临床状态评估来避免。医院质量小组可将退回血液成分的情况作为质量改进项目的目标。
{"title":"S.O.S. – Save our supplies: Understanding reasons to tackle the challenge of wasted returned blood products","authors":"Deep Madkaiker,&nbsp;Kartik Iyer,&nbsp;Jagriti,&nbsp;Deepika Chenna,&nbsp;Ganesh Mohan,&nbsp;Shamee Shastry","doi":"10.1016/j.tracli.2024.01.003","DOIUrl":"10.1016/j.tracli.2024.01.003","url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate the return of blood components across different hospital areas, reasons for the same and suggest preventive strategies which might reduce out of controlled temperature storage (CTS) blood logistics and wastage.</p></div><div><h3>Material and methods</h3><p>A retrospective audit was carried out in the department of Transfusion Medicine from January 2019 to December 2022. Data related to returned blood components was compiled using departmental records and blood centre software entries.</p></div><div><h3>Results</h3><p>A total of 218 instances of returned components were noted and the total number of components returned were 442 (0.4% of all issued components) (38.4% (170) packed red blood cells, 16.2% (72) single donor cryoprecipitate concentrate, 19.6% (87) platelet concentrate and 25.5% (113) fresh frozen plasma). Components were returned back within 30 mins in only 27% (59/218) of all instances . Wards followed by high dependency units/intensive care units were noted to have the highest number of instances (86 (39.4%) and 69 (31.6%) respectively) with emergency department having the least,comprising 19 instances (8.7%). 77.9% (170/218) instances were observed for routine transfusion requests and 44.5% (97/218) of all instances could have been prevented by an appropriate clinical status assessment of the patient.</p></div><div><h3>Conclusion</h3><p>Stakeholders such as clinicians, transfusion laboratory professional and nursing staff must take consolidated efforts to eliminate wastage of blood components. Instances of returned blood components can be targeted by the hospital quality team as a quality improvement project.</p></div>","PeriodicalId":23262,"journal":{"name":"Transfusion Clinique et Biologique","volume":"31 2","pages":"Pages 76-80"},"PeriodicalIF":1.7,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S124678202400003X/pdfft?md5=1c62cd7da2558fd663b25c43b54c68f6&pid=1-s2.0-S124678202400003X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139423763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is prophylactic intraoperative transfusion needed in unilateral total knee arthroplasty? Comparison of hematologic data and postoperative transfusion rate between a prophylactic allogenic or autologous transfusion group with a no-transfusion group: A preliminary retrospective cohort study 单侧全膝关节置换术是否需要预防性术中输血?预防性异体或自体输血组与不输血组血液学数据和术后输血率的比较:初步回顾性队列研究
IF 1.7 4区 医学 Q4 HEMATOLOGY Pub Date : 2024-01-10 DOI: 10.1016/j.tracli.2024.01.002
Hee Jin Seon, Jimin Lee, Seo Kyeong Choi, Jae Ho Lee

Objectives

To determine whether prophylactic intra-operative allogenic or autologous transfusion could prevent postoperative anemia and additional transfusion comparing to the control group without receiving any prophylactic intervention in unilateral total knee arthroplasty.

Materials and methods

This study included 711 patients who underwent unilateral TKA. They were divided into four groups: allogeneic transfusion group (group AL), autologous transfusion group (group AT), tranexamic acid group (group TA), and control group (group C). The primary outcome was rate of postoperative allogeneic blood transfusions. Secondary outcomes were postoperative hemoglobin and hematocrit levels, postoperative bleeding amount.

Results

Groups AT and AL did not exhibit a significant reduction in postoperative allogenic blood transfusion rate compared to group C (28/108 vs. 20/108, p = 0.21 and 37/159 vs. 34/159, p = 0.78 respectively). However, group TA demonstrated a significantly lower rate of postoperative allogenic blood transfusions than group C (22/125 vs. 3/125, p = 0.0001). Postoperative hemoglobin and hematocrit levels were statistically higher in group TA than in group C. However, those levels in group AT and AL did not differ significantly from those of group C.

Conclusion

Intra-operative prophylactic transfusions did not decrease postoperative anemia or additional postoperative transfusion compared to the control group in patients undergoing total knee arthroplasty. However, the group receiving tranexamic acid showed lower transfusion rate and higher levels of hemoglobin and hematocrit.

材料和方法 本研究纳入了 711 例接受单侧全膝关节置换术的患者,将其分为四组:异体输血组(AL 组)、自体输血组(AT 组)和对照组(C 组)。他们被分为四组:异体输血组(AL 组)、自体输血组(AT 组)、氨甲环酸组(TA 组)和对照组(C 组)。主要结果是术后异体输血率。结果与 C 组相比,AT 组和 AL 组的术后异体输血率没有显著降低(分别为 28/108 对 20/108,P = 0.21 和 37/159 对 34/159,P = 0.78)。不过,TA 组的术后异体输血率明显低于 C 组(22/125 对 3/125,P = 0.0001)。结论与对照组相比,术前预防性输血并不能减少全膝关节置换术患者术后贫血或术后额外输血。然而,接受氨甲环酸治疗的一组输血率较低,血红蛋白和血细胞比容水平较高。
{"title":"Is prophylactic intraoperative transfusion needed in unilateral total knee arthroplasty? Comparison of hematologic data and postoperative transfusion rate between a prophylactic allogenic or autologous transfusion group with a no-transfusion group: A preliminary retrospective cohort study","authors":"Hee Jin Seon,&nbsp;Jimin Lee,&nbsp;Seo Kyeong Choi,&nbsp;Jae Ho Lee","doi":"10.1016/j.tracli.2024.01.002","DOIUrl":"10.1016/j.tracli.2024.01.002","url":null,"abstract":"<div><h3>Objectives</h3><p>To determine whether prophylactic intra-operative allogenic or autologous transfusion could prevent postoperative anemia and additional transfusion comparing to the control group without receiving any prophylactic intervention in unilateral total knee arthroplasty.</p></div><div><h3>Materials and methods</h3><p>This study included 711 patients who underwent unilateral TKA. They were divided into four groups: allogeneic transfusion group (group AL), autologous transfusion group (group AT), tranexamic acid group (group TA), and control group (group C). The primary outcome was rate of postoperative allogeneic blood transfusions. Secondary outcomes were postoperative hemoglobin and hematocrit levels, postoperative bleeding amount.</p></div><div><h3>Results</h3><p>Groups AT and AL did not exhibit a significant reduction in postoperative allogenic blood transfusion rate compared to group C (28/108 vs. 20/108, <em>p</em> = 0.21 and 37/159 vs. 34/159, <em>p</em> = 0.78 respectively). However, group TA demonstrated a significantly lower rate of postoperative allogenic blood transfusions than group C (22/125 vs. 3/125, <em>p</em> = 0.0001). Postoperative hemoglobin and hematocrit levels were statistically higher in group TA than in group C. However, those levels in group AT and AL did not differ significantly from those of group C.</p></div><div><h3>Conclusion</h3><p>Intra-operative prophylactic transfusions did not decrease postoperative anemia or additional postoperative transfusion compared to the control group in patients undergoing total knee arthroplasty. However, the group receiving tranexamic acid showed lower transfusion rate and higher levels of hemoglobin and hematocrit.</p></div>","PeriodicalId":23262,"journal":{"name":"Transfusion Clinique et Biologique","volume":"31 2","pages":"Pages 70-75"},"PeriodicalIF":1.7,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139423761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood transfusion knowledge levels of nurses in İzmir Atatürk training and research Hospital, turkey 土耳其伊兹密尔阿塔图尔克培训与研究医院护士的输血知识水平。
IF 1.7 4区 医学 Q4 HEMATOLOGY Pub Date : 2024-01-08 DOI: 10.1016/j.tracli.2024.01.001
Berrin Uzun , Vahide Yılmaz , Selvinaz Göklü , Ufuk Şahbaz , Hayri Güvel

Despite their use in life-saving treatment, blood and blood products can cause life-threatening complications. To administer blood transfusion safely, national guidelines and protocols should be consulted in healthcare organizations. In Türkiye, there are guides and regulations published by the Ministry of Health. With the definition of hemovigilance in the regulations; training in clinical use of blood and transfusion practice fields is now mandatory. This study presents data from a survey designed to assess transfusion knowledge levels of clinical departments for the purpose of planning our training programs.

A two-part survey was conducted on 110 nurses from various departments. Questions included sociodemographic attributes, department they worked in, employment duration, knowledge level on transfusion practices. Statistical analysis was performed.

Of the nurses that participated; 52.7% were above 40 years old, 15.5% were 31–40 years old and 31.8% were below 30 years old. For education; 84.5% of the nurses were graduates or postgraduates. For work experience; 64.5% were working in internal medicine departments, 58.2% had been working as a nurse for 10 or more years while 85.5% worked in the same department for less than 5 years. It was determined that the nurses should know more about transfusion.

Beginner nurses in the intense care unit were found to have lower levels of transfusion practice knowledge, from this it was deduced additional training should be scheduled for beginner nurses with low transfusion knowledge. In addition to theoretical instructions, one-on-one training on operation controls and “observation and guidance” style practical training should be implemented. Theoretical and practical topics with inadequate knowledge should be instructed in finer detail to increase the knowledge level in these subjects.

尽管血液和血液制品可用于救命治疗,但它们也可能引起危及生命的并发症。为了安全输血,医疗机构应参考国家指导方针和协议。土耳其卫生部发布了相关指南和规定。随着条例中对血液警戒的定义,临床用血和输血实践领域的培训现已成为强制性规定。本研究介绍了一项旨在评估临床科室输血知识水平的调查数据,目的是规划我们的培训计划。我们对来自不同科室的 110 名护士进行了一项由两部分组成的调查。问题包括社会人口学属性、工作科室、工作时间、输血知识水平。调查进行了统计分析。在参与调查的护士中,52.7%在 40 岁以上,15.5%在 31-40 岁之间,31.8%在 30 岁以下。学历方面,84.5%的护士为大学毕业生或研究生。在工作经验方面,64.5%的护士在内科工作,58.2%的护士工作了 10 年或 10 年以上,85.5%的护士在同一科室工作了不到 5 年。研究认为,护士应该了解更多输血知识。发现重症监护室的初级护士输血实践知识水平较低,由此推断,应为输血知识水平较低的初级护士安排额外培训。除理论指导外,还应开展一对一的操作控制培训和 "观摩指导 "式的实践培训。对知识不足的理论和实践课题应进行更细致的指导,以提高这些课题的知识水平。
{"title":"Blood transfusion knowledge levels of nurses in İzmir Atatürk training and research Hospital, turkey","authors":"Berrin Uzun ,&nbsp;Vahide Yılmaz ,&nbsp;Selvinaz Göklü ,&nbsp;Ufuk Şahbaz ,&nbsp;Hayri Güvel","doi":"10.1016/j.tracli.2024.01.001","DOIUrl":"10.1016/j.tracli.2024.01.001","url":null,"abstract":"<div><p><span>Despite their use in life-saving treatment, blood and blood products can cause life-threatening complications. To administer </span>blood transfusion<span> safely, national guidelines and protocols should be consulted in healthcare organizations. In Türkiye, there are guides and regulations published by the Ministry of Health. With the definition of hemovigilance in the regulations; training in clinical use of blood and transfusion practice fields is now mandatory. This study presents data from a survey designed to assess transfusion knowledge levels of clinical departments for the purpose of planning our training programs.</span></p><p>A two-part survey was conducted on 110 nurses from various departments. Questions included sociodemographic attributes, department they worked in, employment duration, knowledge level on transfusion practices. Statistical analysis was performed.</p><p>Of the nurses that participated; 52.7% were above 40 years old, 15.5% were 31–40 years old and 31.8% were below 30 years old. For education; 84.5% of the nurses were graduates or postgraduates. For work experience; 64.5% were working in internal medicine departments, 58.2% had been working as a nurse for 10 or more years while 85.5% worked in the same department for less than 5 years. It was determined that the nurses should know more about transfusion.</p><p>Beginner nurses in the intense care unit were found to have lower levels of transfusion practice knowledge, from this it was deduced additional training should be scheduled for beginner nurses with low transfusion knowledge. In addition to theoretical instructions, one-on-one training on operation controls and “observation and guidance” style practical training should be implemented. Theoretical and practical topics with inadequate knowledge should be instructed in finer detail to increase the knowledge level in these subjects.</p></div>","PeriodicalId":23262,"journal":{"name":"Transfusion Clinique et Biologique","volume":"31 2","pages":"Pages 62-69"},"PeriodicalIF":1.7,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-150 Rare cas d’alloimmunisation anti-C Willis: Quel conseil transfusionnel? P-150 抗 C 型威利斯异体免疫的罕见病例:应提供哪些输血建议?
IF 1.7 4区 医学 Q4 HEMATOLOGY Pub Date : 2023-11-01 DOI: 10.1016/j.tracli.2023.09.197
Fattouma Ben Sghaier, N. Siala, Nour Louati, H. Menif, Jalel Gargouri, Taicir Rekik, Ikram Ben Amor
{"title":"P-150 Rare cas d’alloimmunisation anti-C Willis: Quel conseil transfusionnel?","authors":"Fattouma Ben Sghaier, N. Siala, Nour Louati, H. Menif, Jalel Gargouri, Taicir Rekik, Ikram Ben Amor","doi":"10.1016/j.tracli.2023.09.197","DOIUrl":"https://doi.org/10.1016/j.tracli.2023.09.197","url":null,"abstract":"","PeriodicalId":23262,"journal":{"name":"Transfusion Clinique et Biologique","volume":"10 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139306103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CO5-2 Analyse moléculaire du système sanguin érythrocytaire RH au Cameroun 喀麦隆红细胞RH血液系统的CO5-2分子分析
4区 医学 Q4 HEMATOLOGY Pub Date : 2023-11-01 DOI: 10.1016/j.tracli.2023.09.029
Jeanne Manga-Mbeti, Françoise Ngo Sack, Caroline Bénech, Estelle Wete, Hortense Ngnegni, Simon Noël Ateba, Jules Tchatchueng, Alexandre Njan Nloga, Yann Fichou
{"title":"CO5-2 Analyse moléculaire du système sanguin érythrocytaire RH au Cameroun","authors":"Jeanne Manga-Mbeti, Françoise Ngo Sack, Caroline Bénech, Estelle Wete, Hortense Ngnegni, Simon Noël Ateba, Jules Tchatchueng, Alexandre Njan Nloga, Yann Fichou","doi":"10.1016/j.tracli.2023.09.029","DOIUrl":"https://doi.org/10.1016/j.tracli.2023.09.029","url":null,"abstract":"","PeriodicalId":23262,"journal":{"name":"Transfusion Clinique et Biologique","volume":"196 1-2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135565354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-162 Evaluation de la gestion des informations post-don au centre régional de transfusion sanguine de Ouagadougou (Burkina Faso) 瓦加杜古区域输血中心捐赠后信息管理评估(布基纳法索)
4区 医学 Q4 HEMATOLOGY Pub Date : 2023-11-01 DOI: 10.1016/j.tracli.2023.09.210
Seimbou Zalla, Alassane Bazie, Natacha Koala, Anita Siritie, Yetema Dieudonné Yonli, Mahamoudou Sanou
{"title":"P-162 Evaluation de la gestion des informations post-don au centre régional de transfusion sanguine de Ouagadougou (Burkina Faso)","authors":"Seimbou Zalla, Alassane Bazie, Natacha Koala, Anita Siritie, Yetema Dieudonné Yonli, Mahamoudou Sanou","doi":"10.1016/j.tracli.2023.09.210","DOIUrl":"https://doi.org/10.1016/j.tracli.2023.09.210","url":null,"abstract":"","PeriodicalId":23262,"journal":{"name":"Transfusion Clinique et Biologique","volume":"89 1-3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135565406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P-046 Plasma congelé, conservé 10 ans: quelle qualité ? P-046冷冻血浆,保存10年:什么质量?
4区 医学 Q4 HEMATOLOGY Pub Date : 2023-11-01 DOI: 10.1016/j.tracli.2023.09.095
Christian Naegelen, Constant Cretenet, Nadine Marpaux
{"title":"P-046 Plasma congelé, conservé 10 ans: quelle qualité ?","authors":"Christian Naegelen, Constant Cretenet, Nadine Marpaux","doi":"10.1016/j.tracli.2023.09.095","DOIUrl":"https://doi.org/10.1016/j.tracli.2023.09.095","url":null,"abstract":"","PeriodicalId":23262,"journal":{"name":"Transfusion Clinique et Biologique","volume":"70 1-3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135565409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Transfusion Clinique et Biologique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1